Compounds > naltrexone

naltrexone and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

naltrexone has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chin, PY; Diener, KR; Hutchinson, MR; Moldenhauer, LM; Rice, KC; Robertson, SA; Sharkey, DJ; Wahid, HH1

Other Studies

1 other study(ies) available for naltrexone and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

ArticleYear
Toll-Like Receptor-4 Antagonist (+)-Naltrexone Protects Against Carbamyl-Platelet Activating Factor (cPAF)-Induced Preterm Labor in Mice.
    The American journal of pathology, 2020, Volume: 190, Issue:5

    Topics: Animals; Female; Mice; Mice, Inbred BALB C; Naltrexone; Narcotic Antagonists; Obstetric Labor, Premature; Platelet Activating Factor; Pregnancy; Toll-Like Receptor 4

2020